持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/04/27 | 3,530 | 3,570 | 3,500 | 3,525 | -55 | -1.5% | 102,500 |
| 2022/04/26 | 3,625 | 3,640 | 3,580 | 3,580 | -20 | -0.6% | 36,800 |
| 2022/04/25 | 3,575 | 3,615 | 3,560 | 3,600 | -30 | -0.8% | 25,400 |
| 2022/04/22 | 3,610 | 3,635 | 3,595 | 3,630 | -20 | -0.5% | 23,100 |
| 2022/04/21 | 3,645 | 3,680 | 3,640 | 3,650 | ±0 | ±0% | 27,700 |
| 2022/04/20 | 3,620 | 3,670 | 3,610 | 3,650 | +25 | +0.7% | 22,000 |
| 2022/04/19 | 3,660 | 3,660 | 3,605 | 3,625 | -10 | -0.3% | 17,400 |
| 2022/04/18 | 3,685 | 3,700 | 3,585 | 3,635 | -110 | -2.9% | 29,100 |
| 2022/04/15 | 3,720 | 3,760 | 3,720 | 3,745 | +30 | +0.8% | 48,000 |
| 2022/04/14 | 3,700 | 3,745 | 3,685 | 3,715 | -5 | -0.1% | 21,400 |
| 2022/04/13 | 3,640 | 3,730 | 3,630 | 3,720 | +80 | +2.2% | 45,900 |
| 2022/04/12 | 3,725 | 3,725 | 3,625 | 3,640 | -135 | -3.6% | 50,800 |
| 2022/04/11 | 3,685 | 3,775 | 3,685 | 3,775 | +90 | +2.4% | 35,300 |
| 2022/04/08 | 3,720 | 3,720 | 3,640 | 3,685 | -20 | -0.5% | 55,500 |
| 2022/04/07 | 3,690 | 3,705 | 3,630 | 3,705 | -15 | -0.4% | 33,600 |
| 2022/04/06 | 3,770 | 3,810 | 3,720 | 3,720 | -55 | -1.5% | 31,200 |
| 2022/04/05 | 3,780 | 3,800 | 3,745 | 3,775 | +5 | +0.1% | 34,900 |
| 2022/04/04 | 3,730 | 3,785 | 3,730 | 3,770 | +45 | +1.2% | 25,900 |
| 2022/04/01 | 3,710 | 3,755 | 3,690 | 3,725 | -10 | -0.3% | 38,200 |
| 2022/03/31 | 3,835 | 3,850 | 3,725 | 3,735 | -135 | -3.5% | 56,200 |
| 2022/03/30 | 3,995 | 3,995 | 3,835 | 3,870 | -120 | -3% | 55,700 |
| 2022/03/29 | 3,995 | 4,000 | 3,925 | 3,990 | +45 | +1.1% | 52,800 |
| 2022/03/28 | 3,975 | 3,990 | 3,930 | 3,945 | +10 | +0.3% | 39,400 |
| 2022/03/25 | 3,920 | 3,985 | 3,920 | 3,935 | -30 | -0.8% | 29,600 |
| 2022/03/24 | 3,955 | 3,965 | 3,905 | 3,965 | -10 | -0.3% | 28,200 |
| 2022/03/23 | 3,895 | 3,990 | 3,895 | 3,975 | +85 | +2.2% | 42,000 |
| 2022/03/22 | 3,980 | 3,980 | 3,880 | 3,890 | -40 | -1% | 44,700 |
| 2022/03/18 | 3,955 | 3,975 | 3,905 | 3,930 | -25 | -0.6% | 76,800 |
| 2022/03/17 | 3,945 | 3,985 | 3,935 | 3,955 | +25 | +0.6% | 49,900 |
| 2022/03/16 | 3,925 | 3,975 | 3,920 | 3,930 | +5 | +0.1% | 50,500 |
| 2022/03/15 | 3,870 | 3,945 | 3,855 | 3,925 | +65 | +1.7% | 50,400 |
| 2022/03/14 | 3,890 | 3,900 | 3,860 | 3,860 | ±0 | ±0% | 36,500 |
| 2022/03/11 | 3,850 | 3,895 | 3,835 | 3,860 | -25 | -0.6% | 57,900 |
| 2022/03/10 | 3,765 | 3,890 | 3,765 | 3,885 | +155 | +4.2% | 51,100 |
| 2022/03/09 | 3,755 | 3,775 | 3,720 | 3,730 | -40 | -1.1% | 52,800 |
| 2022/03/08 | 3,800 | 3,835 | 3,755 | 3,770 | +40 | +1.1% | 71,400 |
| 2022/03/07 | 3,745 | 3,780 | 3,710 | 3,730 | -15 | -0.4% | 41,500 |
| 2022/03/04 | 3,800 | 3,835 | 3,745 | 3,745 | -55 | -1.4% | 42,000 |
| 2022/03/03 | 3,755 | 3,850 | 3,755 | 3,800 | +45 | +1.2% | 41,000 |
| 2022/03/02 | 3,790 | 3,825 | 3,755 | 3,755 | -85 | -2.2% | 35,600 |
| 2022/03/01 | 3,840 | 3,895 | 3,820 | 3,840 | ±0 | ±0% | 46,700 |
| 2022/02/28 | 3,755 | 3,850 | 3,755 | 3,840 | +105 | +2.8% | 62,500 |
| 2022/02/25 | 3,800 | 3,825 | 3,725 | 3,735 | -75 | -2% | 45,700 |
| 2022/02/24 | 3,805 | 3,820 | 3,775 | 3,810 | +5 | +0.1% | 74,300 |
| 2022/02/22 | 3,840 | 3,855 | 3,785 | 3,805 | -80 | -2.1% | 40,600 |
| 2022/02/21 | 3,855 | 3,890 | 3,835 | 3,885 | +15 | +0.4% | 32,800 |
| 2022/02/18 | 3,805 | 3,885 | 3,800 | 3,870 | +35 | +0.9% | 31,800 |
| 2022/02/17 | 3,860 | 3,880 | 3,835 | 3,835 | -30 | -0.8% | 34,300 |
| 2022/02/16 | 3,840 | 3,875 | 3,830 | 3,865 | +30 | +0.8% | 35,700 |
| 2022/02/15 | 3,820 | 3,875 | 3,815 | 3,835 | +50 | +1.3% | 71,100 |
751～
800
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 297,600円 | +5.1% | -7.0% | 2.69% | 19.54倍 | 0.81倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 297,100円 | +21.7% | +999.9% | 0.00% | 12.45倍 | 4.12倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| ゼリア新薬 | 213,700円 | +3.1% | -6.5% | 2.25% | 9.92倍 | 1.05倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 杏林製薬 | 146,000円 | -2.4% | -52.3% | 3.90% | 17.47倍 | 0.62倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 200,000円 | +4.1% | -3.1% | 2.90% | 17.54倍 | 1.53倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
